What is an Antiwrinkle Treatment?

An antiwrinkle treatment refers to a treatment with Botulinum Toxin (Bot.Tox.). There are 3 approved brands of Bot.Tox. in New Zealand; Botox®, Dysport® and Xeomin®. Bot.Tox is a naturally occurring neurotoxin in nature and is produced by the bacterium Clostridium A.

How does Botulinum Toxin (Bot.Tox.) work to reduce wrinkles?

Bot.Tox. temporarily relaxes muscles by blocking the release of chemicals involved in a normal muscle contraction. This relaxation can improve the appearance of fine lines and wrinkles that are directly associated with muscle movement (eg. frown lines). Although the medicine does not directly treat resting lines, it does minimise the repetitive wrinkle creasing, which can over time soften these lines.

Is it safe?

Yes. The use of Bot.Tox. in medicine has been widely researched and is currently used to treat a variety of medical conditions such as spasticity in children and adults with cerebral palsy, blepharospasm, cervical dystonia and bladder dysfunction in adults.

Results:

The result of an antiwrinkle treatment is temporary and will last, on average, around 3 months. Results are dependent on factors such as your anatomy, treatment expectations and the dose used. It is important to express any concerns you may have with your treatment provider (Registered Nurse, doctor or dentist) during your initial consultation. For those wanting a more natural expression, a lower dose may be more suited. However, it is important to understand that the lower the dose used, the less longevity you will have with your results. Many patients are opting for more natural results that allow them to have some movement in between treatment sessions.

Deciding on a treatment provider

All aesthetic practitioners need to have a practicing certificate in medicine to be able to perform cosmetic injectable treatments in New Zealand.  That is be a Registered Nurse, Medical doctor, or dentist. It is important before booking your appointment that you visit the medical, dental, or nursing council website to ensure your practitioner is registered. It is a requirement that you are to have a consultation by a Medical or Nurse Practitioner before undergoing treatment. This can be done in person or via video call. Often the aesthetic practitioner may suggest something different to your initial expectation, so it is important to be given time to think this information over before deciding on treatment. You should never feel rushed or pressured in any way. CosmeticAID strongly encourages patients to find a practitioner they feel comfortable, and most importantly, safe with. This will be evident in how your practitioner consults you as well as how they conduct their business. You should feel comfortable to ask any questions throughout the consultation and your practitioner must discuss the risks and side effects of botulinum toxin treatment (including but not limited to those listed below). Many of the side effects will be related to the chosen treatment area, so any concerns must be raised with your practitioner before deciding on treatment.

CommonUncommonRare or Very Rare
BruisingSevere bruisingSevere muscle weakness
HeadacheEyelid PtosisDifficulty swallowing
Bleeding – mild at injection siteEyebrow PtosisBlurred Vision
Swelling – mild at injection siteFacial ParesisDouble vision
RednessMuscle weaknessProlonged altered sensation
TendernessFlu like symptomsDouble Vision
DiscomfortNauseaAllergic reaction
ItchinessAltered sensation 
Eyebrow dropInjection haematoma 
 Severe swelling 

NB: Ptosis refers to a drop/droop.

*The above information reflects only some of the more reported adverse events related to Botulinum toxin within aesthetic medicine. CosmeticAID encourages all patients to read the product and consumer medical information of each product (see below links)*

Botox Information: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/PICMI?OpenForm&t=&q=botulinum

Dysport Information: https://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/PICMI?OpenForm&t=&q=clostridium

Xeomin Informationhttps://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/PICMI?OpenForm&t=&q=incobotulinumtoxina